Diabetes is a top election issue 20 May 2016 Diabetes Australia is pleased that diabetes is a key health issue being discussed during the 2016 Federal Election campaign. This is essential because around 1.5 million Australia families are affected by diabetes and the epidemic continues to grow. Diabetes Australia CEO A/Professor Greg Johnson said he looked forward to diabetes announcements from the different parties during the election noting that prevention, care and treatment, hospitalisations and healthcare costs, and access to medicines and technologies were all important policy considerations. He welcomed the Coalition’s recent election commitment to provide $54 million for continuous glucose monitoring (CGM) to support 4,000 children and young people under the age of 21. “The Coalition’s announcement was positive and important to improve access to potentially life saving and life changing diabetes technology and was in line with a proposal Diabetes Australia put forward in partnership with JDRF and clinical experts (Australian Paediatric Endocrine Group, Australian Diabetes Society and Australian Diabetes Educators Association),” A/Professor Johnson said. “However, our proposal was not limited to a particular age group but was targeted towards people with type 1 diabetes at the highest risk and who would benefit the most.” The Diabetes Australia CGM submission outlined the following priorities: Children with type 1 diabetes under 10 for whom hypoglycaemia can have a major adverse effect on the developing brain. Type 1 diabetes is more difficult to manage during childhood which increases the risk of poor metabolic control and hypoglycaemia, both of which may affect brain development and cognition Some people with type 1 diabetes of any age have an impaired physiological awareness of impending hypoglycaemia and suffer from severe hypoglycaemia. These people are at a higher risk of diabetes-related complications During pregnancy, some women with type 1 diabetes experience unstable blood glucose levels which can affect the wellbeing of mother and child. This can increase the risk of pregnancy complications to then mother and the unborn baby. A/Professor Johnson said he was confident Diabetes Australia, and its partners, would work with the next Federal Government to ensure Australian’s with type 1 diabetes at high risk and high need would benefit from CGM. You can read our submission on CGM below.
News 14 May 2024 New PBS listing for treatment of itch associated with chronic kidney disease A new medication has been added to the PBS for people undergoing dialysis and experiencing chronic kidney disease itch. Continue Reading
Blog 13 May 2024 Calls for action on kidney disease screening Dianne Moidin knows better than most about the courage people show when they live with chronic kidney disease. Dianne runs... Continue Reading
News 10 May 2024 Urgent US recall on t:connect app American news media are reporting that the FDA issued a Class 1 recall of t:connect phone app after a malfunction caused pumps to shut down, suspending insulin delivery. Continue Reading